Instalco – El & Säkerhet Sörmland

Buyer: Instalco Intressenter AB (publ.) through subsidiary Instalco Nordic AB

Seller: Management

Target: AB El & Säkerhet Sörmland

Hansen acted as adviser to Instalco on the acquisition of AB El & Säkerhet Sörmland from Management.

Pressrelease (in Swedish)

Investor: Via-ID SAS

Target: UbiGo Innovation AB

Hansen acted as adviser to Via-ID in relation to its investment in UbiGo Innovation AB.

Related article (Swedish)

Buyer: Fidelio

Seller: AniCura

Target: VetFamily

Hansen acted as adviser to the management team in relation to Fidelio’s acquisition of VetFamily from AniCura, and the related management investment.

Investor: Schibsted

Target: Add Health Media

Hansen acted as adviser to Add Health Media in relation to Schibsted’s investment.

Related article (Dagens Industri in Swedish)

Lead Investor: Vostok New Ventures

Target: VOI Technology AB

Hansen acted as adviser to VOI in relation to the USD 30m financing, led by Vostok New Ventures, Creandum and Project A and with participation from certain existing shareholders i.a. Balderton Capital, Raine, Christina Stenbeck, Jeff Wilkes (Amazon),Sujay Tyle (CEO Frontier Car Group) and Spencer Rascoff (ex-CEO of Zillow).

Related article (Techcrunch)

Buyer: Investcorp

Sellers: Valedo Partners Fund II AB

Target: Cambio Holding AB

Hansen acted as adviser to the management team in relation to Investcorp’s acquisition of Cambio from Valedo, and the related management reinvestment.

Pressrelease

Investor: Luminar Ventures

Target: Mindler AB

Hansen acted as adviser to Luminar Ventures in relation to its investment in Mindler.

Related article (Breakit – in Swedish)

Buyer: Blocket AB

Sellers: Founders, employees and i.a. institutional investors

Target: Qasa AB

Hansen acted as adviser to the sellers in relation to the divestment of Qasa to Blocket.

Related article (Dagens Industri in Swedish)

Seller: Moberg Pharma AB (publ.)

Buyer: RoundTable Healthcare Partners and Signet Healthcare Partners

Target: Moberg Pharma OTC business

Hansen acted as adviser to Moberg Pharma on the USD 155m divestment of its OTC business to RoundTable Healthcare Partners and Signet Healthcare Partners.

Pressrelease

Licensor: Moberg Pharma AB (publ.)

Licensee: Bayer

Product: MOB-015

Hansen acted as adviser to Moberg Pharma on the licensing and distribution arrangement for the commercialization of MOB-015 in Europe.

Pressrelease